<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2023-4-737-742</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2245</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL &amp; EXPERIMENTAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Исследование кровоснабжения макулярной области сетчатки при хронических миелопролиферативных заболеваниях</article-title><trans-title-group xml:lang="en"><trans-title>Investigation of Blood Supply to the Macular Region of the Retina in Chronic Myeloproliferative Diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4756-1687</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юнусова</surname><given-names>Э. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Yunusova</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юнусова Эльвира Маратовна заочный аспирант кафедры офтальмологии с курсом ИДПО</p><p>ул. Ленина, 3, Уфа, 450008</p></bio><bio xml:lang="en"><p>Yunusova Elvira M. postgraduate student of the Ophthalmology department</p><p>Lenin str., 3, Ufa, 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3078-2464</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мухамадеев</surname><given-names>Т. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukhamadeev</surname><given-names>T. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мухамадеев Тимур Рафаэльевич доктор медицинских наук, заведующий кафедрой офтальмологии с курсом ИДПО</p><p>ул. Ленина, 3, Уфа, 450008</p></bio><bio xml:lang="en"><p>Mukhamadeev Timur R. MD, head of the Ophthalmology department</p><p>Lenin str., 3, Ufa, 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3297-1608</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бакиров</surname><given-names>Б. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakirov</surname><given-names>B. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бакиров Булат Ахатович доктор медицинских наук, заведующий кафедрой госпитальной терапии № 2</p><p>ул. Ленина, 3, Уфа, 450008</p></bio><bio xml:lang="en"><p>Bakirov Bulat A. MD, head of the Department of hospital therapy No. 2</p><p>Lenin str., 3, Ufa, 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4849-7354</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Идрисова</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Idrisova</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Идрисова Гульназ Маратовна кандидат медицинских наук, ассистент кафедры офтальмологии с курсом ИДПО</p><p>ул. Ленина, 3, Уфа, 450008</p></bio><bio xml:lang="en"><p>Idrisova Gulnaz M. PhD, assistant of the Department of ophthalmology</p><p>Lenin str., 3, Ufa, 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Башкирский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>27</day><month>12</month><year>2023</year></pub-date><volume>20</volume><issue>4</issue><fpage>737</fpage><lpage>742</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юнусова Э.М., Мухамадеев Т.Р., Бакиров Б.А., Идрисова Г.М., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Юнусова Э.М., Мухамадеев Т.Р., Бакиров Б.А., Идрисова Г.М.</copyright-holder><copyright-holder xml:lang="en">Yunusova E.M., Mukhamadeev T.R., Bakirov B.A., Idrisova G.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2245">https://www.ophthalmojournal.com/opht/article/view/2245</self-uri><abstract><p>Хронические миелопролиферативные заболевания (ХМПЗ) — опухолевые заболевания кроветворной ткани с усиленной пролиферацией одной или нескольких линий миелопоэза. Достаточно часто при данной патологии можно встретить упоминания о поражении органа зрения. При ХМПЗ наблюдаются изменения в составе периферической крови, приводящие к изменению реологии крови и способствующие ухудшению микроциркуляции тканей глаз. Помимо этого, аномальная пролиферация гемопоэтических клеток и длительная специфическая терапия ослабляют иммунную систему организма, способствуя развитию системного воспаления. Данные процессы могут приводить к ухудшению кровоснабжения тканей глаз, в частности в макулярной области. Цель работы — оценить плотность сосудов (VD) в поверхностном и глубоком сосудистых сплетениях сетчатки и площадь фовеолярной аваскулярной зоны (FAZ) при помощи оптической когерентной томографии с функцией ангиографии (ОКТА) у пациентов с ХМПЗ. Пациенты и методы. В исследование включены 25 пациентов с ХМПЗ (50 глаз), а также 20 добровольцев (40 глаз), сопоставимых по полу и возрасту, без гемобластоза в анамнезе. Всем обследованным проведена комплексная офтальмологическая диагностика, включающая ОКТА. Результаты. По результатам проведенной работы у пациентов с ХМПЗ выявлено достоверное снижение VD во всех секторах (кроме фовеолярной зоны) в обоих исследуемых сосудистых сплетениях, а также достоверное увеличение площади FAZ по сравнению с группой контроля. Заключение. Снижение VD в сосудистых сплетениях сетчатки, а также увеличение площади FAZ являются признаками ухудшения ретинального кровоснабжения и ишемии сетчатки. Не исключается, что к данным изменениям могут привести нарушения реологии крови, а также хроническое системное воспаление, наблюдаемые у пациентов с ХМПЗ. Ухудшение кровотока и длительная гипоксия сетчатки могут способствовать серьезным нарушениям зрительных функций пациентов. В связи с этим больным с ХМПЗ требуется более детальное наблюдение, возможно, с коррекцией основного лечения.</p></abstract><trans-abstract xml:lang="en"><p>Chronic myeloproliferative diseases (CMPD) are tumor diseases of hematopoietic tissue with increased proliferation of one or more lines of myelopoiesis. Quite often with this pathology there are find references to damage to the organ of vision. With CMPD changes in the composition of peripheral blood are observed, leading to changes in the rheology of blood and contributing to the deterioration of microcirculation of eye tissues. In addition, abnormal proliferation of hematopoietic cells and prolonged specific therapy weaken the body’s immune system, contributing to the development of systemic inflammation. These processes can lead to deterioration of blood supply to eye tissues, in particular in the macular region. Purpose. To evaluate vessel density (VD) in the superficial and deep vascular plexuses of retina and the area of foveolar avascular zone (FAZ) using optical coherence tomography with angiography function (OCTA) in patients with CMPD. Patients and methods. The study included 25 patients with CMPD (50 eyes) and 20 volunteers (40 eyes), comparable in gender and age, without a history of hemoblastosis. All the examined patients underwent comprehensive ophthalmological diagnostics, including OCTA. Results. According to the results, patients with CMPD revealed a significant decrease in VD in all sectors (except the foveolar zone) in both studied vascular plexuses, as well as a significant increase in area of FAZ compared to the control group. Conclusion. A decrease in VD in the vascular plexuses of the retina, as well as an increase in area of FAZ, are signs of deterioration of retinal blood supply and retinal ischemia. It is possible that these changes may lead to violations of blood rheology, as well as chronic systemic inflammation observed in patients with CMPD. Deterioration of blood flow and prolonged retinal hypoxia can contribute to serious visual impairment of patients. In this regard, patients with CMPD require more detailed monitoring, possibly with correction of the main treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хронические миелопролиферативные заболевания</kwd><kwd>плотность сосудов</kwd><kwd>фовеолярная аваскулярная зона</kwd><kwd>реология крови</kwd><kwd>системное воспаление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic myeloproliferative diseases</kwd><kwd>vascular density</kwd><kwd>foveolar avascular zone</kwd><kwd>blood rheology</kwd><kwd>systemic inflammation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Керимов А.А. Хронические миелопролиферативные заболевания: современное состояние вопроса. Биомедицина. 2014;3:3–8.</mixed-citation><mixed-citation xml:lang="en">Kerimov AA. Chronic myeloproliferative diseases: current state of the issue. Biomedicine. 2014;3: 3–8 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Мошетова Л.К., Егорян Л.Б., Виноградова О.Ю., Туркина К.И., Шихбабаева Д.И. Современные представления об офтальмологических проявлениях хронических миелопролиферативных новообразований. Вестник Российской академии медицинских наук. 2023;78(3):208–212. doi: 10.15690/vramn2277.</mixed-citation><mixed-citation xml:lang="en">Moshetova LK, Egoryan LB, Vinogradova OJ, Turkina KI, Shikhbabaeva DI. Contemporary interpretations of ophthalmological manifestations of chronic myeloproliferative neoplasms. Bulletin of the Russian Academy of Medical Sciences. 2023;78(3):208–212 (In Russ.). doi: 10.15690/vramn2277.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Чухланцева Е.А. Геморрагический синдром и состояние системы гемостаза при остром лейкозе. Материалы X Междунар. студ. науч. конф. «Студенческий научный форум» URL: https://scienceforum.ru/2018/article/2018003096 (дата обращения: 16.08.2023).</mixed-citation><mixed-citation xml:lang="en">Chukhlantseva ЕА. Hemorrhagic syndrome and the state of the hemostatic system in acute leukemia. Materials of the X International Student Scientific Conference “Student Scientific Forum.URL:  https://scienceforum.ru/2018/article/2018003096 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Румянцева, Ю.В., Карачунский А.И. Оптимизация терапии острого лимфобластного лейкоза у детей в России и Белоруссии: стратегия Москва — Берлин. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2007;6(4):13.</mixed-citation><mixed-citation xml:lang="en">Rumyantseva YV, Karachunsky AI. Optimization of therapy for acute lymphoblastic leukemia in children in Russia and Byelorussia: the Moscow-Berlin strategy. Issues of hematology/oncology and immunopathology in pediatrics. 2007;6(4):13 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dhasmana R, Prakash A, Gupta N, Verma SK. Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters. Ann Afr Med. 2016;15(3):97–103. doi: 10.4103/1596-3519.188887.</mixed-citation><mixed-citation xml:lang="en">Dhasmana R, Prakash A, Gupta N, Verma SK. Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters. Ann Afr Med. 2016;15(3):97–103. doi: 10.4103/1596-3519.188887.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Soman S, Kasturi N, Srinivasan R, Vinod KV. Ocular manifestations in leukemias and their correlation with hematologic parameters at a tertiary care setting in South India. Ophthalmol. Retina. 2018;2(1):17–23. doi: 10.1016/j.oret.2017.05.009.</mixed-citation><mixed-citation xml:lang="en">Soman S, Kasturi N, Srinivasan R, Vinod KV. Ocular manifestations in leukemias and their correlation with hematologic parameters at a tertiary care setting in South India. Ophthalmol. Retina. 2018;2(1):17–23. doi: 10.1016/j.oret.2017.05.009.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mohamed SF, Qatami A, Nashwan A, Abdulla MA, Yassin MA. Ophthalmologic Manifestations as Initial Presentation of Patients with Chronic Myeloid Leukemia: Report of Two Cases. Case Rep Oncol. 2020;13(1):7–11. doi: 10.1159/000504928.</mixed-citation><mixed-citation xml:lang="en">Mohamed SF, Qatami A, Nashwan A, Abdulla MA, Yassin MA. Ophthalmologic Manifestations as Initial Presentation of Patients with Chronic Myeloid Leukemia: Report of Two Cases. Case Rep Oncol. 2020;13(1):7–11. doi: 10.1159/000504928.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Руднева Л.Ф., Василькова Т.Н., Петров И.М., Пономарева М.Н. Гемобластозы. Особенности поражения глаз. Тюмень: Коновалов И.С., 2020. 90 с.</mixed-citation><mixed-citation xml:lang="en">Rudneva LF, Vasil’kova TN, Petrov IM, Ponomareva MN. Hemoblastoses. Features of eye damage. Tyumen: Konovalov IS., 2020. 90 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ghanbarnia M, Sedaghat S, Rasoulinejad SA. Leukemic retinopathy presenting as concurrent bilateral subhyaloid hemorrhage and subarachnoid hemorrhage in a patient with acute monocytic leukemia: a case report. J Med Case Rep. 2022;16(1):466. doi: 10.1186/s13256-022-03700-4.</mixed-citation><mixed-citation xml:lang="en">Ghanbarnia M, Sedaghat S, Rasoulinejad SA. Leukemic retinopathy presenting as concurrent bilateral subhyaloid hemorrhage and subarachnoid hemorrhage in a patient with acute monocytic leukemia: a case report. J Med Case Rep. 2022;16(1):466. doi: 10.1186/s13256-022-03700-4.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Shah SB, Reichstein DA, Lally SE, Shields CL. Persistent bloody tears as the initial manifestation of conjunctival chloroma associated with chronic myelogenous leukemia. Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):991–992. doi: 10.1007/s00417-011-1924-1.</mixed-citation><mixed-citation xml:lang="en">Shah SB, Reichstein DA, Lally SE, Shields CL. Persistent bloody tears as the initial manifestation of conjunctival chloroma associated with chronic myelogenous leukemia. Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):991–992. doi: 10.1007/s00417-011-1924-1.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Гришина Е.Е., Мамонтов А.О. Офтальмологические проявления лейкоза. Альманах клинической медицины. 2016;44(5):587–591. doi: 10.18786/20720505-2016-44-5-587-591.</mixed-citation><mixed-citation xml:lang="en">Grishina EE, Mamontov AO. Ophthalmic manifestations of leukemia. Almanac of clinical medicine. 2016;44(5):587–591 (In Russ.). doi: 10.18786/2072-0505-2016-44-5587-591.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Чистякова Н.В. Офтальмологические проявления лейкозов. Офтальмологические ведомости. 2016;9(2):81–99. doi: 10.17816/OV9281-99.</mixed-citation><mixed-citation xml:lang="en">Chistyakova NV. Ophthalmic manifestation of leukemia. Ophthalmology journal. 2016;9(2):81–99 (In Russ.). doi: 10.17816/OV9281-99.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Abe S, Shiono T. Retinochoroidal circulatory disturbances and blood component abnormalities. Nippon Ganka Gakkai Zasshi. 1995 Mar.;99(3):255–261.</mixed-citation><mixed-citation xml:lang="en">Abe S, Shiono T. Retinochoroidal circulatory disturbances and blood component abnormalities. Nippon Ganka Gakkai Zasshi. 1995 Mar.;99(3):255–261.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Азнабаев Б.М., Мухамадеев Т.Р., Дибаев Т.И. Оптическая когерентная томография + ангиография в диагностике, терапии и хирургии глазных болезней. М.: Август Борг, 2019. 352 с.</mixed-citation><mixed-citation xml:lang="en">Aznabaev BM, Mukhamadeev TR, Dibaev TI. Optical coherence tomography + angiography in the diagnosis, therapy and surgery of eye diseases. Moscow: Avgust Borg, 2019. 352 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bhanushali D, Anegondi N, Gadde SG, Srinivasan P. Linking retinal microvasculature features with severity of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):519–525. doi: 10.1167/iovs.15-18901.</mixed-citation><mixed-citation xml:lang="en">Bhanushali D, Anegondi N, Gadde SG, Srinivasan P. Linking retinal microvasculature features with severity of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):519–525. doi: 10.1167/iovs.15-18901.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chen L, Yuan M, Sun L, Wang Y, Chen Y. Evaluation of microvascular network with optical coherence tomography angiography (OCTA) in branch retinal vein occlusion (BRVO). BMC Ophthalmol. 2020 Apr 19;20(1):154. doi: 10.1186/s12886-02001405-0.</mixed-citation><mixed-citation xml:lang="en">Chen L, Yuan M, Sun L, Wang Y, Chen Y. Evaluation of microvascular network with optical coherence tomography angiography (OCTA) in branch retinal vein occlusion (BRVO). BMC Ophthalmol. 2020 Apr 19;20(1):154. doi: 10.1186/s12886-02001405-0.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kal M, Platkowska-Adamska B, Zarębska-Michaluk D, Rzymski P. Reduced vessel density and enlarged foveal avascular zone in the macula as a result of systemic hypoxia caused by SARS-CoV-2 infection. J Pers Med. 2023 May 31;13(6):926. doi: 10.3390/jpm13060926.</mixed-citation><mixed-citation xml:lang="en">Kal M, Platkowska-Adamska B, Zarębska-Michaluk D, Rzymski P. Reduced vessel density and enlarged foveal avascular zone in the macula as a result of systemic hypoxia caused by SARS-CoV-2 infection. J Pers Med. 2023 May 31;13(6):926. doi: 10.3390/jpm13060926.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Platelets. 2006 Dec;17(8):528–544. doi: 10.1080/09537100600758677.</mixed-citation><mixed-citation xml:lang="en">Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Platelets. 2006 Dec;17(8):528–544. doi: 10.1080/09537100600758677.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Азнабаева Л.Ф., Плотникова С.В., Сафуанова Г.Ш. Предикторы воспаления (sICAM-1 и провоспалительные цитокины) у больных острым лейкозом. Цитокины и воспаление. 2015;14(1):38–42.</mixed-citation><mixed-citation xml:lang="en">Aznabaeva LF, Plotnikova SV, Safuanova GSh. Predictors of inflammation (sICAM-1 and pro-inflammatory cytokines in patients with acute leukemia. Cytokines and inflammation. 2015;14(1):38–42 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Nobacht S, Vandoninck KF, Deutman AF, Klevering BJ. Peripheral retinal nonperfusion associated with chronic myeloid leukemia. Am J Ophthalm. 2003 Mar;135(3):404–406. doi: 10.1016/s0002-9394(02)01956-6.</mixed-citation><mixed-citation xml:lang="en">Nobacht S, Vandoninck KF, Deutman AF, Klevering BJ. Peripheral retinal nonperfusion associated with chronic myeloid leukemia. Am J Ophthalm.  2003 Mar;135(3):404–406. doi: 10.1016/s0002-9394(02)01956-6.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Chen Y, Zhang Y, Shen T, Shen X. Changes in retinal circulation and choroidal thickness in patients with acute myeloid leukemia detected by optical coherence tomography angiography. Front Med 2023. Mar 13;10:1117204. doi: 10.3389/fmed.2023.1117204.</mixed-citation><mixed-citation xml:lang="en">Yang L, Chen Y, Zhang Y, Shen T, Shen X. Changes in retinal circulation and choroidal thickness in patients with acute myeloid leukemia detected by optical coherence tomography angiography. Front Med 2023. Mar 13;10:1117204. doi: 10.3389/fmed.2023.1117204.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
